Thermogenesis Holdings Inc - ESG Rating & Company Profile powered by AI
Check the end of this webpage for potential risks for Thermogenesis Holdings Inc based on industry, location and marketcap. Alternative companies in the rating industry group for Thermogenesis Holdings Inc are displayed below. If you work at Thermogenesis Holdings Inc and you wish to use your ESG rating, please contact us.
Thermogenesis Holdings Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 8.0, social score of 2.7 and governance score of 5.3.
5.3
Medium ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1737978896147)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
139 | Itama Ranoraya PT | 5.4 | High |
139 | PW Medtech Group Ltd | 5.4 | High |
145 | Thermogenesis Holdings Inc | 5.3 | High |
145 | Branded Legacy Inc | 5.3 | High |
145 | Ameco Medical Industries SAE | 5.3 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1737978896147)
Frequently Asked Questions
Does Thermogenesis Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Does Thermogenesis Holdings Inc disclose current and historical energy intensity?
Does Thermogenesis Holdings Inc report the average age of the workforce?
Does Thermogenesis Holdings Inc reference operational or capital allocation in relation to climate change?
Does Thermogenesis Holdings Inc disclose its ethnicity pay gap?
Does Thermogenesis Holdings Inc disclose cybersecurity risks?
Does Thermogenesis Holdings Inc offer flexible work?
Does Thermogenesis Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Thermogenesis Holdings Inc disclose the number of employees in R&D functions?
Does Thermogenesis Holdings Inc conduct supply chain audits?
Does Thermogenesis Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Thermogenesis Holdings Inc conduct 360 degree staff reviews?
Does Thermogenesis Holdings Inc disclose the individual responsible for D&I?
Does Thermogenesis Holdings Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Thermogenesis Holdings Inc disclose current and / or historical scope 2 emissions?
Does Thermogenesis Holdings Inc disclose water use targets?
Does Thermogenesis Holdings Inc have careers partnerships with academic institutions?
Did Thermogenesis Holdings Inc have a product recall in the last two years?
Does Thermogenesis Holdings Inc disclose incidents of discrimination?
Does Thermogenesis Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Has Thermogenesis Holdings Inc issued a profit warning in the past 24 months?
Does Thermogenesis Holdings Inc disclose parental leave metrics?
Does Thermogenesis Holdings Inc disclose climate scenario or pathway analysis?
Does Thermogenesis Holdings Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Thermogenesis Holdings Inc disclose the pay ratio of women to men?
Does Thermogenesis Holdings Inc support suppliers with sustainability related research and development?
Does Thermogenesis Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Thermogenesis Holdings Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Thermogenesis Holdings Inc involved in embryonic stem cell research?
Does Thermogenesis Holdings Inc disclose GHG and Air Emissions intensity?
Does Thermogenesis Holdings Inc disclose its waste policy?
Does Thermogenesis Holdings Inc report according to TCFD requirements?
Does Thermogenesis Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Thermogenesis Holdings Inc disclose energy use targets?
Does Thermogenesis Holdings Inc disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Thermogenesis Holdings Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Thermogenesis Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.